Insider Sale: CFO Brandon O'Brien Sells Shares of CorVel Corp (CRVL)

Article's Main Image

On August 21, 2024, Brandon O'Brien, Chief Financial Officer of CorVel Corp (CRVL, Financial), executed a sale of 1,000 shares of the company at a price of $314.98 per share. This transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 6,502 shares of CorVel Corp.

CorVel Corp is a provider of healthcare management services and solutions for workers' compensation, auto and liability, group health, and disability insurance markets. The company offers services such as claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and Medicare services.

Over the past year, Brandon O'Brien has sold a total of 4,113 shares and has not purchased any shares. This recent transaction continues a trend seen within the company, where there have been 33 insider sells and no insider buys over the last year.

Shares of CorVel Corp were trading at $314.98 on the day of the sale, giving the company a market cap of approximately $5.39 billion. The price-earnings ratio of the stock stands at 69.75, significantly higher than the industry median of 11.46 and above the historical median for the company.

The stock's current price also reflects a significant premium according to the GF Value, with a price-to-GF-Value ratio of 1.32, indicating that the stock is Significantly Overvalued. The GF Value of $239.30 is calculated considering historical trading multiples, an adjustment factor based on past performance, and future business performance estimates.

1827198232745373696.png

1827198284775714816.png

This insider sale might interest investors tracking insider behaviors as an indicator of the company's future performance or stock valuation adjustments.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.